Long intergenic non-protein coding RNA 3019 (LINC03019)

Long intergenic non-protein coding RNA 3019 (LINC03019) is a long intergenic non-coding RNA (lincRNA), which means it is a transcribed RNA molecule longer than 200 nucleotides that does not overlap protein-coding genes[1][3]. LINC03019, like other lincRNAs, is not translated into protein but instead is implicated in the *regulation of gene expression*, chromatin structure, and possibly enhancer activity[1][3][7]. LincRNAs such as LINC03019 can fine-tune the expression of neighboring genes, often in a tissue-specific manner, and may participate in the regulation of processes relevant to development and disease, notably including cancer[3]. However, LINC03019 itself is not a canonical therapeutic target like a receptor, enzyme, or transporter; rather, it is a regulatory RNA whose functional relevance to disease may still be under research. There are no reported drug interactions, mechanisms of action, established biomarkers, or specific safety concerns associated with LINC03019 to date[1].

Other names

RP11-252C15.1LINC03019